EV/EBITDA
-13.86
+0.05+0.36%
Fri, 29 Nov 2024 21:58:05 GMT
Summary:
CRISPR Therapeutics AG EV/EBITDA is currently -13.86, with a rise of +0.05 (+0.36%) during the most recent trading day. Over the past year, it has dropped by -0.93 (-7.19%). CRSP EV/EBITDA is now -100.64% below its all-time high of 2149.62.CRSP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +0.4% |
| 1 m1 month | -4.3% |
| 3 m3 months | -20.9% |
| 6 m6 months | +4.2% |
| ytdytd | +42.4% |
| 1 y1 year | -7.2% |
| 5 y5 years | +98.1% |
CRSP EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -12.71 | -9.1% | -15.14 | +8.4% |
| 3 m | 3 months | -10.65 | -30.1% | -15.14 | +8.4% |
| 6 m | 6 months | -10.65 | -30.1% | -18.32 | +24.3% |
| 1 y | 1 year | -10.65 | -30.1% | -36.33 | +61.9% |
| 3 y | 3 years | 15.82 | -187.6% | -36.33 | +61.9% |
| 5 y | 5 years | 2149.62 | -100.6% | -732.31 | +98.1% |
| alltime | all time | 2149.62 | -100.6% | -732.31 | +98.1% |
CRISPR Therapeutics AG EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -13.86(-42.4%) |
| 2023 | -24.05(+371.6%) |
| 2022 | -5.10(-138.9%) |
| 2021 | 13.12(-144.4%) |
| Date | Value |
|---|---|
| 2020 | -29.57(-154.1%) |
| 2019 | 54.62(-928.8%) |
| 2018 | -6.59(-43.1%) |
| 2017 | -11.58(-67.5%) |
| 2016 | -35.60 |
FAQ
- What is CRISPR Therapeutics AG EV/EBITDA?
- What is the all time high EV/EBITDA for CRISPR Therapeutics AG?
- What is CRSP EV/EBITDA year-to-date change?
- What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
What is CRISPR Therapeutics AG EV/EBITDA?
The current EV/EBITDA of CRSP is -13.86
What is the all time high EV/EBITDA for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high EV/EBITDA is 2149.62
What is CRSP EV/EBITDA year-to-date change?
CRISPR Therapeutics AG EV/EBITDA has changed by +10.19 (+42.37%) since the beginning of the year
What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
Over the past year, CRSP EV/EBITDA has changed by -0.93 (-7.19%)